Pancreatic cancer
Conditions
Interventions
Gold Standard:Collect the pathological diagnosis results and treatment information of the two groups (if surgery is performed, collect postoperative pathology
if chemotherapy is administered, collect imaging data during chemotherapy
if under follow-up observation, collect imaging data). Use the final surgical pathology or imaging results at 6 months of follow-up.
Index test:EUS-FNA diagnosis combined with modified ROSE
Sponsors
Peking University First Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients suspected of having a solid pancreatic lesion based on imaging (CT or MRI), aged 18-80 years, with no obvious contraindications to puncture (such as coagulation disorders or gastrointestinal obstruction); 2. Planned to undergo EUS-FNA examination before surgery or chemotherapy to obtain histopathological or cytopathological diagnosis; 3. The subject personally agrees and voluntarily signs the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Have clear puncture contraindications (coagulation dysfunction, gastrointestinal obstruction, etc.); 2. Those who refuse to sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnosis rates in both groups; | — |
Secondary
| Measure | Time frame |
|---|---|
| specificity;The accuracy of the two groups of diagnoses;number of punctures;Negative predicted value;Post-puncture complications;operating time;sensitivity;Positive predicted value; | — |
Countries
China
Contacts
Public ContactCai Yunlong
Peking University First Hospital
Outcome results
None listed